Literature DB >> 25984582

Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions.

Ashish Gurav1, Sathish Sivaprakasam1, Yangzom D Bhutia2, Thomas Boettger3, Nagendra Singh1, Vadivel Ganapathy4.   

Abstract

Mammalian colon harbours trillions of bacteria under physiological conditions; this symbiosis is made possible because of a tolerized response from the mucosal immune system. The mechanisms underlying this tolerogenic phenomenon remain poorly understood. In the present study we show that Slc5a8 (solute carrier gene family 5a, member 8), a Na(+)-coupled high-affinity transporter in colon for the bacterial fermentation product butyrate, plays a critical role in this process. Among various immune cells in colon, dendritic cells (DCs) are unique not only in their accessibility to luminal contents but also in their ability to induce tolerogenic phenotype in T-cells. We found that DCs exposed to butyrate express the immunosuppressive enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and aldehyde dehydrogenase 1A2 (Aldh1A2), promote conversion of naive T-cells into immunosuppressive forkhead box P3(+) (FoxP3(+)) Tregs (regulatory T-cells) and suppress conversion of naive T-cells into pro-inflammatory interferon (IFN)-γ-producing cells. Slc5a8-null DCs do not induce IDO1 and Aldh1A2 and do not generate Tregs or suppress IFN-γ-producing T-cells in response to butyrate. We also provide in vivo evidence for an obligatory role for Slc5a8 in suppression of IFN-γ-producing T-cells. Furthermore, Slc5a8 protects against colitis and colon cancer under conditions of low-fibre intake but not when dietary fibre intake is optimal. This agrees with the high-affinity nature of the transporter to mediate butyrate entry into cells. We conclude that Slc5a8 is an obligatory link between dietary fibre and mucosal immune system via the bacterial metabolite butyrate and that this transporter is a conditional tumour suppressor in colon linked to dietary fibre content.
© 2015 Authors; published by Portland Press Limited.

Entities:  

Keywords:  3-dioxygenase 1; bacterial metabolites; butyrate transporter; colitis; colon cancer; dendritic cell; dietary fibre; histone deacetylase; indoleamine 2; member 8 (Slc5a8)-null mouse; solute carrier gene family 5a

Mesh:

Substances:

Year:  2015        PMID: 25984582      PMCID: PMC4943859          DOI: 10.1042/BJ20150242

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.

Authors:  Nagendra Singh; Ashish Gurav; Sathish Sivaprakasam; Evan Brady; Ravi Padia; Huidong Shi; Muthusamy Thangaraju; Puttur D Prasad; Santhakumar Manicassamy; David H Munn; Jeffrey R Lee; Stefan Offermanns; Vadivel Ganapathy
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

2.  Generation of mucosal dendritic cells from bone marrow reveals a critical role of retinoic acid.

Authors:  Ting Feng; Yingzi Cong; Hongwei Qin; Etty N Benveniste; Charles O Elson
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

Review 3.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Puttur D Prasad
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

4.  Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.

Authors:  Muthusamy Thangaraju; Kristina N Carswell; Puttur D Prasad; Vadivel Ganapathy
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

Review 5.  The core gut microbiome, energy balance and obesity.

Authors:  Peter J Turnbaugh; Jeffrey I Gordon
Journal:  J Physiol       Date:  2009-06-02       Impact factor: 5.182

Review 6.  IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Authors:  Andrew L Mellor; David H Munn
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

7.  Induction of the cystine/glutamate exchanger SLC7A11 in retinal pigment epithelial cells by the antipsoriatic drug monomethylfumarate.

Authors:  Sudha Ananth; Ellappan Babu; Rajalakshmi Veeranan-Karmegam; Brooke R Bozard Baldowski; Thomas Boettger; Pamela M Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-01       Impact factor: 4.799

Review 8.  Regulatory T cells in inflammatory bowel disease.

Authors:  Elisa K Boden; Scott B Snapper
Journal:  Curr Opin Gastroenterol       Date:  2008-11       Impact factor: 3.287

9.  SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.

Authors:  Hui Li; Lois Myeroff; Dominic Smiraglia; Michael F Romero; Theresa P Pretlow; Lakshmi Kasturi; James Lutterbaugh; Ronald M Rerko; Graham Casey; Jean-Pierre Issa; Joseph Willis; James K V Willson; Christoph Plass; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

10.  Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.

Authors:  Cheng-Ming Sun; Jason A Hall; Rebecca B Blank; Nicolas Bouladoux; Mohamed Oukka; J Rodrigo Mora; Yasmine Belkaid
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

View more
  51 in total

1.  Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation.

Authors:  Fengqi Hao; Miaomiao Tian; Xinbo Zhang; Xin Jin; Ying Jiang; Xue Sun; Yang Wang; Pinghui Peng; Jia Liu; Chaoyi Xia; Yunpeng Feng; Min Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

2.  Short, but Smart: SCFAs Train T Cells in the Gut to Fight Autoimmunity in the Brain.

Authors:  Yangzom D Bhutia; Vadivel Ganapathy
Journal:  Immunity       Date:  2015-10-20       Impact factor: 31.745

Review 3.  Microbes, metabolites, and the gut-lung axis.

Authors:  Anh Thu Dang; Benjamin J Marsland
Journal:  Mucosal Immunol       Date:  2019-04-11       Impact factor: 7.313

Review 4.  A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier.

Authors:  Wangxin Liu; Xianliang Luo; Jun Tang; Qiufen Mo; Hao Zhong; Hui Zhang; Fengqin Feng
Journal:  Eur J Nutr       Date:  2020-11-12       Impact factor: 5.614

Review 5.  Short-Chain Fatty Acid Transporters: Role in Colonic Homeostasis.

Authors:  Sathish Sivaprakasam; Yangzom D Bhutia; Shengping Yang; Vadivel Ganapathy
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

Review 6.  The gut-bone axis: how bacterial metabolites bridge the distance.

Authors:  Mario M Zaiss; Rheinallt M Jones; Georg Schett; Roberto Pacifici
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

Review 7.  Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.

Authors:  Mingming Sun; Wei Wu; Zhanju Liu; Yingzi Cong
Journal:  J Gastroenterol       Date:  2016-07-23       Impact factor: 7.527

Review 8.  SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms.

Authors:  Yangzom D Bhutia; Ellappan Babu; Sabarish Ramachandran; Shengping Yang; Muthusamy Thangaraju; Vadivel Ganapathy
Journal:  Biochem J       Date:  2016-05-01       Impact factor: 3.857

9.  Catalpol alleviates renal damage by improving lipid metabolism in diabetic db/db mice.

Authors:  Pingping Jiang; Lei Xiang; Zewei Chen; Hanqi Lu; Lin Zhou; Lebin Yang; Yanzhao Ji; Yanyan Liu; Xiaomin Sun; Yingfeng Deng; Xiaoli Nie; Ren Luo; Xiaoshan Zhao
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

Review 10.  Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk.

Authors:  Derek V Seidel; M Andrea Azcárate-Peril; Robert S Chapkin; Nancy D Turner
Journal:  Semin Cancer Biol       Date:  2017-07-01       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.